ヘルプ
ヘルプ

検索結果 145 件

EJC supplements

EJC supplements
紙雑誌
Pergamon<Z78-A166>
国立国会図書館全国の図書館
  •  
  •  
  •  
  •  
  •  
    •  

The hallmarks of ovarian cancer: Focus on angiogenesis and micro-environment and new models for their characterisation

The hallmarks of ovarian cancer: Focus on angiogenesis and micro-environment and new models for their characterisation
デジタル記事
2020-08European Journal of Cancer Supplements15p.49-55
全国の図書館
  • 掲載誌（ISSN）13596349

Cardiovascular disease after cancer therapy

Cardiovascular disease after cancer therapy
デジタル記事
2014-06European Journal of Cancer Supplements12 1p.18-28
全国の図書館
  • 掲載誌（ISSN）13596349

Current knowledge and future research directions in treatment-related second primary malignancies

Current knowledge and future research directions in treatment-related second primary malignancies
デジタル記事
2014-06European Journal of Cancer Supplements12 1p.5-17
全国の図書館
  • 掲載誌（ISSN）13596349

Targeted therapy in melanoma – the role of BRAF, RAS and KIT mutations

Targeted therapy in melanoma – the role of BRAF, RAS and KIT mutations
デジタル記事
2013-09European Journal of Cancer Supplements11 2p.92-96
全国の図書館
  • 掲載誌（ISSN）13596349

Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors

Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors
デジタル記事
2013-09European Journal of Cancer Supplements11 2p.172-191
全国の図書館
  • 掲載誌（ISSN）13596349

The seventh tumour–node–metastasis staging system for lung cancer: Sequel or prequel?

The seventh tumour–node–metastasis staging system for lung cancer: Sequel or prequel?
デジタル記事
2013-09European Journal of Cancer Supplements11 2p.150-158
全国の図書館
  • 掲載誌（ISSN）13596349

EORTC Radiation Oncology Group: 50 years of continuous accomplishments

EORTC Radiation Oncology Group: 50 years of continuous accomplishments
デジタル記事
2012-03European Journal of Cancer Supplements10 1p.150-159
全国の図書館
  • 掲載誌（ISSN）13596349

414 Clinical pharmacokinetics and pharmacodynamics of CX-4945, a novel inhibitor of protein kinase CK2: Interim report from the phase 1 clinical trial

414 Clinical pharmacokinetics and pharmacodynamics of CX-4945, a novel inhibitor of protein kinase CK2: Interim report from the phase 1 clinical trial
デジタル記事
2010-11European Journal of Cancer Supplements8 7p.131-132
全国の図書館
  • 掲載誌（ISSN）13596349

375 A Phase 1 dose escalation study of the oral heat shock protein 90 (Hsp90) inhibitor PF-04929113/SNX-5422 (PF-113) and its associated ocular toxicity

375 A Phase 1 dose escalation study of the oral heat shock protein 90 (Hsp90) inhibitor PF-04929113/SNX-5422 (PF-113) and its associated ocular toxicity
デジタル記事
2010-11European Journal of Cancer Supplements8 7p.119-
全国の図書館
  • 掲載誌（ISSN）13596349

223 Trastuzumab-DM1: mechanisms of action and mechanisms of resistance

223 Trastuzumab-DM1: mechanisms of action and mechanisms of resistance
デジタル記事
2010-11European Journal of Cancer Supplements8 7p.73-
全国の図書館
  • 掲載誌（ISSN）13596349

313 Resistance to the microtubule-stabilizing agents, peloruside A and laulimalide, is associated with multiple b-tubulin alterations

313 Resistance to the microtubule-stabilizing agents, peloruside A and laulimalide, is associated with multiple b-tubulin alterations
デジタル記事
2010-11European Journal of Cancer Supplements8 7p.100-
全国の図書館
  • 掲載誌（ISSN）13596349

251 Potent and efficient testosterone suppression by chronic administration of novel metastin analogues, TAK-448 and TAK-683, in male rats

251 Potent and efficient testosterone suppression by chronic administration of novel metastin analogues, TAK-448 and TAK-683, in male rats
デジタル記事
2010-06European Journal of Cancer Supplements8 5p.66-
全国の図書館
  • 掲載誌（ISSN）13596349

611 Homologous recombination in cancer development, treatment and development of drug resistance

611 Homologous recombination in cancer development, treatment and development of drug resistance
デジタル記事
2010-06European Journal of Cancer Supplements8 5p.156-
全国の図書館
  • 掲載誌（ISSN）13596349

19 Extranodal or primary CNS DLBC lymphoma?

19 Extranodal or primary CNS DLBC lymphoma?
デジタル記事
2010-04European Journal of Cancer Supplements8 4p.13-
全国の図書館
  • 掲載誌（ISSN）13596349

500 Is risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer beneficial with respect to distant disease free survival and overall survival?

500 Is risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer beneficial with respect to distant disease free survival and overall survival?
デジタル記事
2010-03European Journal of Cancer Supplements8 3p.206-
全国の図書館
  • 掲載誌（ISSN）13596349

63 A comparison of physician and patient perceptions of clinically important endpoints in the treatment of Metastatic Breast Cancer (MBC)

63 A comparison of physician and patient perceptions of clinically important endpoints in the treatment of Metastatic Breast Cancer (MBC)
デジタル記事
2010-03European Journal of Cancer Supplements8 3p.77-
全国の図書館
  • 掲載誌（ISSN）13596349

24 Zoledronic acid (ZOL) as add-on therapy in patients with tumour residuals after neoadjuvant chemotherapy for primary breast cancer – first interim safety analysis of the NATAN study (GBG 36)

24 Zoledronic acid (ZOL) as add-on therapy in patients with tumour residuals after neoadjuvant chemotherapy for primary breast cancer – first interim safety analysis of the NATAN study (GBG 36)
デジタル記事
2010-03European Journal of Cancer Supplements8 3p.65-
全国の図書館
  • 掲載誌（ISSN）13596349

9304 Identification of tumor biopsy markers as potential predictors of ipilimumab clinical activity in patients with advanced melanoma

9304 Identification of tumor biopsy markers as potential predictors of ipilimumab clinical activity in patients with advanced melanoma
デジタル記事
2009-09European Journal of Cancer Supplements7 2p.577-
全国の図書館
  • 掲載誌（ISSN）13596349

6536 Feasibility of adjuvant S-1 plus docetaxel against stage II-III gastric cancer following R0 resection in gastrectomy

6536 Feasibility of adjuvant S-1 plus docetaxel against stage II-III gastric cancer following R0 resection in gastrectomy
デジタル記事
2009-09European Journal of Cancer Supplements7 2p.372-
全国の図書館
  • 掲載誌（ISSN）13596349